NORFOLK, Va. (AP) — A research firm in Virginia says it has gotten a federal license to import high-quality extracts of marijuana for medical research.
The Virginian-Pilot reported Wednesday that Sanyal Biotechnology will soon embark on a series of critical studies into treatment of various diseases and disorders.
Sanyal CEO Rebecca Caffrey said the license is the broadest ever issued to a U.S. company. And it allows it allows the firm to import high-quality cannabis extracts that aren’t available in the U.S.
Sanyal operates out of Eastern Virginia Medical School in Norfolk. The company says it’s looking to develop a clinical research facility.
The future research headquarters may not be in Virginia. But the company said it still wants to conduct a 200-person clinical trial in the state’s Hampton Roads region.